SenzaGen AB (26S)

Overview

SenzaGen AB is a pioneering company incorporated in 2010, based in Lund, Sweden, specializing in the development of non-animal test methods for assessing the allergenicity of substances. Leveraging innovative in vitro techniques, it provides a range of tests aimed at identifying chemical sensitizers for skin and respiratory paths, as well as determining their potency. In its commitment to replace traditional animal testing methods, SenzaGen collaborates with notable partners, including the Research Institute for Fragrance Materials, to advance the science of allergen detection. This is part of its broader effort to offer alternatives that are not only humane but also precise and reliable, meeting the needs of various industries including pharmaceuticals, chemicals, and medical devices.

Products and Services

• GARDskin – This in vitro test stands out for its ability to identify potential chemical skin sensitizers without animal testing. It's a cornerstone technology that reflects SenzaGen's commitment to innovative, ethical research practices.
• GARDpotency – An in vitro add-on test to GARDskin, GARDpotency classifies the potency of identified sensitizers, providing additional qualitative data crucial for safety assessments.
• GARDskin Dose-response – Offering a more nuanced analysis, this in vitro test quantifies the skin sensitizing potency of chemicals, presenting a significant advancement in the precision of allergenicity assessments.
• GARDair – Expanding its scope beyond skin sensitization, SenzaGen introduces an in vitro method for identifying chemical respiratory sensitizers, addressing a critical aspect of occupational and consumer health.
• GARDskin medical device – Specifically designed for the medical devices sector, this in vitro skin sensitization test caters to the unique requirements of the industry, ensuring that materials are safe and non-irritating for patient use.
• Additional Testing Services – Beyond its flagship products, SenzaGen also offers a suite of services for irritation, corrosion, and absorption testing, making it a comprehensive provider for allergenicity and safety testing.

The company extends its reach through a network of license partners and distributors, enabling it to serve a global clientele effectively. This strategy not only maximizes the accessibility of its unique testing solutions but also underscores SenzaGen's role as a leader in the field of non-animal testing for allergenicity assessment.